Keystone Symposia On Molecular And Cellular Biology

Keystone Symposia On Molecular And Cellular Biology, a Colorado-based tax-exempt nonprofit organization, receives federal grant funding as a recipient to organize and convene scientific conferences in biomedical research, operating exclusively as a prime grant recipient with no federal contract awards or subcontract roles.

Keystone Symposia operates as a nonprofit convener of peer-reviewed scientific meetings. The organization does not conduct its own research or deliver services to agencies; instead, it receives direct federal research grants from the National Institutes of Health (NIH) to host conferences designed to advance specific fields of molecular and cellular biology. The funding mechanism is project grants under the NIH's discretionary grant authority, not procurement contracts. All 701 awards in the source are prime federal grants, not subcontracts or vendor contracts.

The federal customer concentration is extreme and reflects NIH's research mission. The National Institute of Allergy and Infectious Diseases (NIAID) has funded 83 awards, the National Cancer Institute (NCI) has funded 44, and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has funded 37. Other significant NIH funders include the National Heart Lung and Blood Institute, the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, the National Center for Advancing Translational Sciences, and the National Institute of Child Health and Human Development. These five NIH institutes and centers account for over 78 percent of awards by count. Beyond NIH, the source shows minimal activity; the vendor has occasional grants from the National Center for Complementary and Integrative Health, the National Institutes of Biomedical Imaging and Bioenginering, and the National Human Genome Research Institute. No contracts with defense, civilian, or independent agencies appear in the award history.

The conference portfolio spans cancer immunology, infectious disease, aging, metabolic disease, and developmental biology. Recent conferences funded include "Tumor Microenvironment: Identifying Drivers of Progression and Resistance" (NCI, $25 thousand, May 2026), "Neurodegeneration: From Neurocentric to System-Wide Perspectives" (National Institute of Neurological Disorders and Stroke, June 2026), "Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations" (NCI, March 2026), and "B Cells and Plasma Cells: Fundamental and Translational Biology" (NIAID, March 2026). Conferences are held worldwide, with venues in Keystone and Santa Fe, Colorado; Whistler, British Columbia; and international locations including Germany, South Korea, and Japan. Each conference award supports 2–4 day scientific symposia organized with external scientist-organizers; NIH provides grant support for administrative and logistical costs.

Activity has remained stable, with 10–33 awards per year over the past five years. The most recent award is dated June 2026 (one month ago); 13 awards have ultimate completion dates within the next 24 months, indicating ongoing pipeline pressure for recompete. The combined potential value across all 701 awards is $32 thousand (likely an artifact of the source's reporting of small or placeholder grant amounts), but the source also reports $10.9 million in combined obligated dollars, suggesting actual historical spending is an order of magnitude higher. The gap between potential and obligated values reflects the grant recipient model: annual grants are funded in tranches, and obligated dollars reflect actual federal spending on conference execution to date.

Keystone Symposia occupies a non-traditional federal funding relationship. The vendor is not a federal contractor competing for procurements and does not serve as a subcontractor to integrators or prime contractors. Instead, Keystone Symposia is an NIH-funded nonprofit convener, entirely reliant on peer-reviewed grant awards, with no commercial or procurement footprint in the federal contracting ecosystem. The organization has no set-aside or small-business certifications, no contract vehicles, and no subcontracting network. Federal customers view Keystone Symposia as a scientific partner and conference operator, not a service provider or vendor.